Fig. 3From: Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trialRepeated EOC CM injections lead to continued protection against CKD-associated glomerular capillary rarefaction. Kidney sections were immunolabelled with JG-12 antibody, which binds to aminopeptidase P, a glomerular endothelial antigen. Representative images are presented. Original magnification ×400. Quantification is presented in the lower right corner, following sampling of 30 randomly selected glomeruli cut through the macula densa per kidney section (n = 11, No Therapy; n = 8, Initial Therapy Only; n = 7, Repeat Therapy). *p < 0.05 vs. SNX animals receiving No Therapy. AU arbitrary unitsBack to article page